DEF 14A: Blue Star Foods Corp. Seeks Stockholder Approval for Share Issuance, Reverse Stock Split, and Director Elections at Upcoming Annual Meeting

Blue Star Foods Corp. is holding its 2024 Annual Meeting of Stockholders on December 16, 2024, to vote on key proposals including director elections, share issuance approval, a reverse stock split, and ratification of the independent auditor.

Summary

• Blue Star Foods Corp. will hold its 2024 Annual Meeting of Stockholders on December 16, 2024, in Miami, Florida.
• Stockholders will vote on five proposals: electing five directors, approving a share issuance, approving a reverse stock split, ratifying the appointment of MaloneBailey, LLP as the independent auditor, and transacting other business.
• The Board of Directors recommends voting in favor of all proposals.
• The share issuance proposal seeks approval for issuing more than 20% of the company's common stock in a non-public offering, as required by Nasdaq rules.
• The reverse stock split proposal aims to amend the company's certificate of incorporation to effect a reverse stock split with a ratio between 1-for-2 and 1-for-20, determined by the Board.
• The record date for determining stockholders eligible to vote is October 21, 2024.
• The company's Common Stock closed at $0.65 per share on Nasdaq as of the Record Date.
• The company received a notice from Nasdaq on October 16, 2024, stating that it is not in compliance with the minimum bid price requirement of $1.00 per share for continued listing.
• The company requested a hearing with the Nasdaq Hearings Panel, which is scheduled for December 11, 2024.
• The fee for the hearing was $20,000.

Sentiment

Score: 4

Explanation: The document presents a mixed sentiment. While it outlines necessary corporate actions like the reverse stock split and share issuance, it also highlights the company's non-compliance with Nasdaq listing requirements and potential dilution for stockholders. The need for these actions suggests underlying financial challenges, resulting in a moderately negative sentiment.

Positives

• The Board is taking steps to regain compliance with Nasdaq listing requirements through the proposed reverse stock split.
• The company is seeking stockholder approval for a share issuance, which could provide necessary capital.
• The company has a code of ethics in place for its executive officers, directors, and employees.

Negatives

• The company received a notice from Nasdaq for non-compliance with the minimum bid price requirement.
• The company's Common Stock closed at $0.65 per share on Nasdaq as of the Record Date.
• The company may need to issue shares of Common Stock to investors at a price that is less than the Nasdaq Minimum Price, which may result in an issuance equal to 20% or more of the Common Stock outstanding before the issuance.
• The issuance of shares of Common Stock to the investors would result in an increase in the number of shares of Common Stock outstanding, and our stockholders will incur dilution of their percentage ownership.

Risks

• Failure to approve the share issuance proposal could require the company to repay obligations in cash, potentially impacting its capital and operations.
• Failure to regain compliance with Nasdaq listing requirements could result in delisting and impaired liquidity of the Common Stock.
• The reverse stock split may not increase the stock price sufficiently to meet Nasdaq requirements.
• Future transactions could result in substantial dilution of existing stockholders' ownership.
• The company remains indebted to John Keeler under outstanding promissory notes in the aggregate principal amount of $165,620 as of January 1, 2024.

Future Outlook

The company intends to regain compliance with Nasdaq listing requirements and successfully implement its business plans, which are dependent on raising capital and satisfying ongoing business needs.

Management Comments

• The Board of Directors recommends that you vote in favor of each of the proposals.
• The Board has determined that it is in the best interests of the Company and its shareholders to combine these roles.
• Due to the small size and early stage of the Company, the Board believes it is currently most effective to have the Chairman and Chief Executive Officer positions combined.
• In addition, having one person serve as both Chairman and Chief Executive Officer provides clear leadership for the Company, with a single person setting the tone and managing our operations.

Industry Context

The document does not provide specific details on how this announcement relates to broader industry trends or competitors. However, the need for a reverse stock split to maintain Nasdaq listing suggests potential challenges in meeting market expectations or financial performance compared to industry peers.

Comparison to Industry Standards

• The document does not provide specific details on how this announcement relates to global benchmarks.
• The need for a reverse stock split to maintain Nasdaq listing suggests potential challenges in meeting market expectations or financial performance compared to industry peers.
• Many companies in similar situations implement cost-cutting measures, explore strategic partnerships, or seek additional funding to improve their financial position and stock price.

Related Party Transactions

• As of January 1, 2024, the Company remains indebted to Mr. Keeler under the remaining outstanding promissory notes in the aggregate principal amount of $165,620.
• John Keeler, our Chief Executive Officer, Executive Chairman and director owns 95% of Bacolod, an exporter of pasteurized crab meat from the Philippines.
• John Keeler, our Chief Executive Officer, Executive Chairman and director, owns 95% of Bicol, a Philippine company, and an indirect supplier of crab meat via Bacolod to the Company.
• There was $1,299,984 due as of December 31, 2023 for future shipments from Bacolod.

Stakeholder Impact

• Stockholders may experience dilution of their ownership percentage due to the potential share issuance.
• The reverse stock split could affect the market price and liquidity of the Common Stock.
• Employees and other stakeholders could be affected by the company's ability to raise capital and maintain its Nasdaq listing.

Next Steps

• Stockholders to vote on the proposals at the Annual Meeting on December 16, 2024.
• The Board to determine the exact ratio for the reverse stock split if approved.
• The company to attend a hearing with the Nasdaq Hearings Panel on December 11, 2024.
• The company to file a registration statement with the Securities and Exchange Commission to register the re-sale of the maximum number of shares of Common Stock covered in the August Private Placement Offering within sixty (60) calendar days from the date of execution.

Key Dates

Keywords

Annual Meeting, Proxy Statement, Reverse Stock Split, Share Issuance, Board of Directors, Nasdaq, Stockholders, Directors, Common Stock, Compliance